PURA Confirms Increased Investment In ALKM

Rhea-AI Summary

Puration, Inc. (OTC Pink: PURA) announced an increased investment in Alkame Holdings, Inc. (OTC Pink: ALKM), building on a previous 5% stake acquisition. The funds will support the development of new CBD-infused products, with ALKM handling formulation and production, while North American Cannabis Holdings, Inc. (OTC Pink: USMJ) manages marketing. The investment transaction is expected to conclude next week, signaling a strategic partnership in the CBD market.

Positive

• Increased investment in Alkame Holdings, Inc. suggests confidence in product development.
• Collaboration with established companies (ALKM and USMJ) could enhance market presence.
• Focus on development of CBD-infused products aligns with growing industry demand.

Negative

• Risks related to the expectation of achieving significant sales may impact financial performance.
• Potential challenges in meeting performance requirements could affect overall success.

Dallas, Texas, June 11, 2021 (GLOBE NEWSWIRE) -- Puration, Inc. (OTC Pink: PURA) today confirmed it will increase its investment in Alkame Holdings, Inc. (OTC Pink: ALKM).

In an earlier capital investment initiative, PURA acquired a five percent interest in ALKM. 

PURA is working with ALKM and North American Cannabis Holdings, Inc. (OTC Pink: USMJ) in the development of a series of new CBD infused products.  PURA’s new investment will be directed at funding ALKM to formulate the products and set up the ALKM plant for producing the products. USMJ will manage marketing of the new CBD infused products.

The investment transaction is expected to be finalized next week.

For more information on Puration, visit http://www.purationinc.com
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
+1 (800) 861-1350

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Puration, Inc. will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

FAQ

What is Puration's investment plan with Alkame Holdings?

Puration plans to increase its investment in Alkame Holdings, focusing on developing new CBD-infused products.

When is the investment transaction between Puration and Alkame expected to be finalized?

The investment transaction is expected to be finalized next week.

What role does North American Cannabis Holdings play in Puration's new products?

North American Cannabis Holdings will manage the marketing of the new CBD-infused products developed by Puration and Alkame.

How much of Alkame Holdings does Puration currently own?

Puration currently owns a 5% stake in Alkame Holdings.

What risks are associated with Puration's investment strategy?

Puration's investment strategy involves risks such as the expectation of significant sales and the ability to meet performance requirements.